ArticlePharmaceuticals (Basel, Switzerland)2023

Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment.

Lina Keutzer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.